MilliporeSigma Announces Completion of New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

BURLINGTON, Mass.: Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment serves customers in addressing larger patient populations with new curative treatments Enables suspension production of viral vectors up to 1,000-liter scale Project adds to company’s ambition to accelerate growth through investments in "Big 3" businesses, which includes plans to expand Process Solutions’ contract manufacturing and development organization (CDMO) services for traditional and novel modalities
Click here to view original post